All Stories

  1. The Efficacy and Safety of B-Cell Maturation Antigen (BCMA) Antibody-Drug Conjugates (ADC) in Development against Cancer: A Systematic Review
  2. A Brief History of Ebolavirus Disease: Paving the Way Forward by Learning from the Previous Outbreaks
  3. Synthesis and Enhanced Cellular Uptake In Vitro of Anti-HER2 Multifunctional Gold Nanoparticles
  4. Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation
  5. Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
  6. Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines
  7. Analysis of the interaction of para-sulfonatocalix[8]arene with free amino acids and a six residue segment of β-amyloid peptide as a potential treatment for Alzheimer’s disease
  8. Demonstration of In Vitro Host-Guest Complex Formation and Safety of para-Sulfonatocalix[8]arene as a Delivery Vehicle for Two Antibiotic Drugs
  9. Ionic liquids as biocompatible stabilizers of proteins
  10. Choline ionic liquid enhances the stability of Herceptin® (trastuzumab)
  11. Crimean–Congo Hemorrhagic Fever: A bibliometric assessment of the literature
  12. The state-of-play and future of antibody therapeutics
  13. Development of Effective Anticancer Drug Candidates against Breast and Colon Cancers
  14. Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry
  15. Poly (methyl vinyl ether-co-maleic acid) – Pectin based hydrogel-forming systems: Gel, film, and microneedles
  16. Palladium N-Heterocyclic Carbene Complexes: Synthesis from Benzimidazolium Salts and Catalytic Activity in Carbon-carbon Bond-forming Reactions
  17. New compounds based on a benzimidazole nucleus: synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines
  18. Carbon-carbon bond formation catalyzed by PEPPSI Pd-NHC
  19. Nile Red fluorescence spectrum decomposition enables rapid screening of large protein aggregates in complex biopharmaceutical formulations like influenza vaccines
  20. Laboratory Scale Production and Purification of a Therapeutic Antibody
  21. Biobetters From an Integrated Computational/Experimental Approach
  22. Rational design of rabies vaccine formulation for enhanced stability
  23. The effect of deuterium oxide on the conformational stability and aggregation of bovine serum albumin
  24. Host-Guest Complexes of Carboxylated Pillar[ n ]arenes With Drugs
  25. Pd complexes as catalysts for Suzuki-Miyaura reaction
  26. In vitro cytotoxic activities of new silver and PEPPSI palladium N-heterocyclic carbene complexes derived from benzimidazolium salts
  27. Lack of a synergistic effect of arginine–glutamic acid on the physical stability of spray-dried bovine serum albumin
  28. BSA aggregation
  29. Benzimidazolium-based novel silver N-heterocyclic carbene complexes: synthesis, characterisation and in vitro antimicrobial activity
  30. ChemInform Abstract: N-Methylphthalimide-Substituted Benzimidazolium Salts and PEPPSI Pd-NHC Complexes: Synthesis, Characterization and Catalytic Activity in Carbon-Carbon Bond-Forming Reactions.
  31. Flu virus split ratio
  32. N-Methylphthalimide-substituted benzimidazolium salts and PEPPSI Pd–NHC complexes: synthesis, characterization and catalytic activity in carbon–carbon bond-forming reactions
  33. Mechanistic insights into protein aggregation and the development of rational approaches and predictive tools to stabilization of biopharmaceuticals
  34. A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding
  35. Stability of monoclonal antibodies
  36. Evaluation of a Non-Arrhenius Model for Therapeutic Monoclonal Antibody Aggregation
  37. Prediction of protein binding regions
  38. Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies
  39. Tryptophan-Tryptophan Energy Transfer and Classification of Tryptophan Residues in Proteins Using a Therapeutic Monoclonal Antibody as a Model
  40. Prediction of Aggregation Prone Regions of Therapeutic Proteins
  41. Design and Application of Antibody Cysteine Variants
  42. Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation
  43. Predictive tools for stabilization of therapeutic proteins
  44. Aggregation-Prone Motifs in Human Immunoglobulin G
  45. Design of therapeutic proteins with enhanced stability
  46. Comparison of the ATP Binding Sites of Protein Kinases Using Conformationally Diverse Bisindolylmaleimides
  47. Energy Migration in Novel pH-Triggered Self-Assembled β-Sheet Ribbons
  48. Femtosecond Electron-Transfer Reactions in Mono- and Polynucleotides and in DNA